Synthon Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SIPONIMOD ADIPIC ACID, with a corresponding US DMF Number 41019.
Remarkably, this DMF maintains an Active status since its submission on September 25, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 22, 2025, and payment made on September 23, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II